B7-H6を標的とする二特異抗体とIL-15による二重T/NK細胞の関与は,化学療法に抵抗する固体腫瘍を根絶する
Xuqian Ma1,2, Huixia He2, Yuankui Zhu2
1College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Frontiers in immunology
|August 28, 2025
まとめ
B7-H6を標的にする2種類の抗体は,固体腫瘍と戦うために免疫細胞をリダイレクトします. サイトカイン工学と組み合わせたこのアプローチは 耐火性がんを最小限の毒性で治療する見込みを示しています
科学分野:
- 免疫学
- 腫瘍学
- バイオテクノロジー
背景:
- B7-H6は悪性腫瘍に過剰発現する腫瘍特有の免疫チェックポイント分子です.
- B7-H6はがん治療の有望な治療目標です
- B7-H6を標的にすると 癌細胞を選択的に排除し 普通の組織は保存できます
研究 の 目的:
- 固体腫瘍に対するT細胞とNK細胞をリダイレクトするために,B7-H6を標的とする双固体抗体 (BsAbs) を開発する.
- 臨床前モデルにおけるB7- H6標的のBsAbsの有効性と安全性の評価
- BsAbsとサイトカイン工学を含む組み合わせ療法戦略を探求する.
主な方法:
- ファグディスプレイを用いた高親和性B7-H6単体抗体の生成
- T細胞結合 (B7-H6M4-OKT3) とNK細胞結合 (B7-H6M4-LC21) の構造 BsAbs.
- 異種移植モデルにおけるBsAbsの親和性,がん細胞系に対する細胞毒性,およびin vivo有効性の評価
主要な成果:
- 最適化されたBsAbsは,B7-H6+がん細胞に対するナノモラー親和性と選択的な細胞毒性を示した.
- B7-H6M4-LC21は,IL- 15/ IL- 15Ra寿司融合タンパク質と併用すると,腫瘍殺菌効果が強化された.
- 異種移植モデルでは,BsAbsが腫瘍の成長を抑制し,有意な毒性が示されなかった.
- B7- H6M4- LC21とシトカイン融合タンパク質を併用した治療は,相乗効果の腫瘍抑制を達成した.
結論:
- B7-H6標的のBsAbsは,固体腫瘍に対する免疫細胞のリダイレクトに有効です.
- BsAbsとサイトカイン工学の組み合わせ治療は,耐火性固体腫瘍の治療に有効な戦略を提供します.
- このアプローチは,好ましい安全性プロファイルを持つ重要な治療の可能性を示しています.
関連する概念動画
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
01:22T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K